scispace - formally typeset
Search or ask a question
Institution

Allegheny University of the Health Sciences

About: Allegheny University of the Health Sciences is a based out in . It is known for research contribution in the topics: Population & Gene. The organization has 1606 authors who have published 1208 publications receiving 79787 citations.


Papers
More filters
Journal ArticleDOI
TL;DR: A five‐level classification system analogous to the staging and grading systems used in medicine, which has application for clinical practice, research, teaching, and administration is developed.
Abstract: To address the need for a standardized system to classify the gross motor function of children with cerebral palsy, the authors developed a five-level classification system analogous to the staging and grading systems used in medicine. Nominal group process and Delphi survey consensus methods were used to examine content validity and revise the classification system until consensus among 48 experts (physical therapists, occupational therapists, and developmental pediatricians with expertise in cerebral palsy) was achieved. Interrater reliability (kappa) was 0.55 for children less than 2 years of age and 0.75 for children 2 to 12 years of age. The classification system has application for clinical practice, research, teaching, and administration.

5,582 citations

Journal ArticleDOI
04 Apr 1997-Science
TL;DR: Marrow stromal cells present an intriguing model for examining the differentiation of stem cells and have several characteristics that make them potentially useful for cell and gene therapy.
Abstract: Marrow stromal cells can be isolated from other cells in marrow by their tendency to adhere to tissue culture plastic The cells have many of the characteristics of stem cells for tissues that can roughly be defined as mesenchymal, because they can be differentiated in culture into osteoblasts, chondrocytes, adipocytes, and even myoblasts Therefore, marrow stromal cells present an intriguing model for examining the differentiation of stem cells Also, they have several characteristics that make them potentially useful for cell and gene therapy

4,740 citations

Journal ArticleDOI
TL;DR: Improvements in total body bone mineral content and growth velocity were associated with increases in growth velocity and reduced frequencies of bone fracture, indicating the feasibility of allogeneic bone marrow transplantation in the treatment of osteogenesis imperfecta and perhaps other mesenchymal stem cell disorders as well.
Abstract: In principle, transplantation of mesenchymal progenitor cells would attenuate or possibly correct genetic disorders of bone, cartilage and muscle, but clinical support for this concept is lacking. Here we describe the initial results of allogeneic bone marrow transplantation in three children with osteogenesis imperfecta, a genetic disorder in which osteoblasts produce defective type I collagen, leading to osteopenia, multiple fractures, severe bony deformities and considerably shortened stature. Three months after osteoblast engraftment (1.5-2.0% donor cells), representative specimens of trabecular bone showed histologic changes indicative of new dense bone formation. All patients had increases in total body bone mineral content ranging from 21 to 29 grams (median, 28), compared with predicted values of 0 to 4 grams (median, 0) for healthy children with similar changes in weight. These improvements were associated with increases in growth velocity and reduced frequencies of bone fracture. Thus, allogeneic bone marrow transplantation can lead to engraftment of functional mesenchymal progenitor cells, indicating the feasibility of this strategy in the treatment of osteogenesis imperfecta and perhaps other mesenchymal stem cell disorders as well.

1,911 citations

Journal ArticleDOI
TL;DR: In this article, a panel of experts agreed on the validity of 28 criteria describing the potentially inappropriate use of medication by general populations of the elderly as well as 35 criteria defining potentially inappropriate medication use in older persons known to have any of 15 common medical conditions.
Abstract: This study updates and expands explicit criteria defining potentially inappropriate medication use by the elderly. Additional goals were to address whether adverse outcomes were likely to be clinically severe and to incorporate clinical information on diagnoses when available. These criteria are meant to serve epidemiological studies, drug utilization review systems, health care providers, and educational efforts. Consensus from a panel of 6 nationally recognized experts on the appropriate use of medication in the elderly was sought. The expert panel agreed on the validity of 28 criteria describing the potentially inappropriate use of medication by general populations of the elderly as well as 35 criteria defining potentially inappropriate medication use in older persons known to have any of 15 common medical conditions. Updated, expanded, and more generally applicable criteria are now available to help identify inappropriate use of medications in elderly populations. These criteria define medications that should generally be avoided in the ambulatory elderly, doses or frequencies of administrations that should generally not be exceeded, and medications that should be avoided in older persons known to have any of several common conditions.

1,383 citations

Journal ArticleDOI
TL;DR: The results suggest that MSCs may be useful vehicles for autotransplantation in both cell and gene therapy for a variety of diseases of the central nervous system.
Abstract: Neurotransplantation has been used to explore the development of the central nervous system and for repair of diseased tissue in conditions such as Parkinson’s disease. Here, we examine the effects of direct injection into rat brain of human marrow stromal cells (MSCs), a subset of cells from bone marrow that include stem-like precursors for nonhematopoietic tissues. Human MSCs isolated by their adherence to plastic were infused into the corpus striatum. Five to 72 days later, brain sections were examined for the presence of the donor cells. About 20% of the infused cells had engrafted. There was no evidence of an inflammatory response or rejection. The cells had migrated from the injection site along known pathways for migration of neural stem cells to successive layers of the brain. After infusion into the brain, the human MSCs lost their immunoreactivity to antibodies for collagen I. Initially, the human cells continued to stain with antibodies to fibronectin but the region of staining with fibronectin was significantly decreased at 30 and 72 days. The results suggest that MSCs may be useful vehicles for autotransplantation in both cell and gene therapy for a variety of diseases of the central nervous system.

988 citations


Authors

Showing all 1606 results

NameH-indexPapersCitations
Peter Libby211932182724
Edna B. Foa12958873034
Darwin J. Prockop12857687066
Francis E. Marchlinski10976246117
Junichi Sadoshima9939144931
David H. Sachs9690646904
David B. Weiner9066031778
Cato T. Laurencin9044834504
Gary J. Bennett8821628341
Grant L. Iverson8549933622
Douglas F. Levinson8526748963
Galina K. Sukhova8418131165
Michael C. Phillips8422122873
Reed E. Pyeritz8334331814
Glenn Regehr7927123295
Network Information
Related Institutions (5)
Beth Israel Deaconess Medical Center
52.5K papers, 2.9M citations

90% related

Icahn School of Medicine at Mount Sinai
76K papers, 3.7M citations

89% related

Johns Hopkins University School of Medicine
79.2K papers, 4.7M citations

89% related

Baylor College of Medicine
94.8K papers, 5M citations

89% related

United States Department of Veterans Affairs
70.9K papers, 3.2M citations

89% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
20211
20201
20151
20111
20093
20082